RetinalGenix Technologies (RTGN) Interest Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Interest Expenses of $1260.0 for Q1 2026, up 31.25% on a YoY basis from $960.0 in Q1 2025, and up 17.98% sequentially from $1068.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Interest Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Interest Expenses data on file, last reported at $1260.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 31.25% year-over-year to $1260.0; the trailing twelve-month figure through Mar 2026 stood at $4248.0 (down 59.81% YoY), and the FY2025 full-year result was $5.6 million, up 14.75% from the prior year.
- Interest Expenses rose to $1260.0 in Q1 2026, from $1068.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $350175.0 in Q3 2023 to a low of $960.0 in Q4 2022.
- A 5-year average of $22555.2 and a median of $960.0 in 2022 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses surged 27669.63% in 2023 and sank 97.8% in 2024, its largest moves.
- Tracing RTGN's Interest Expenses over 5 years: stood at $960.0 in 2022, then changed by 0.0% to $960.0 in 2023, then changed by 0.0% to $960.0 in 2024, then grew by 11.25% to $1068.0 in 2025, then gained by 17.98% to $1260.0 in 2026.
- Business Quant data shows RTGN's Interest Expenses at $1260.0 in Q1 2026, $1068.0 in Q4 2025, and $960.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 1,260.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,260.00 |
| Mar 31, 2026 | 1,260.00 |
| Dec 31, 2025 | 1,068.00 |
| Dec 31, 2025 | 1,068.00 |
| Sep 30, 2025 | 960.00 |
| Sep 30, 2025 | 960.00 |
| Jun 30, 2025 | 10,425.00 |
| Jun 30, 2025 | 10,425.00 |
| Mar 31, 2025 | 960.00 |
| Mar 31, 2025 | 960.00 |
| Dec 31, 2024 | 960.00 |
| Dec 31, 2024 | 960.00 |
| Sep 30, 2024 | 7,689.00 |
| Sep 30, 2024 | 7,689.00 |
| Jun 30, 2024 | 960.00 |
| Jun 30, 2024 | 960.00 |
| Mar 31, 2024 | 960.00 |
| Mar 31, 2024 | 960.00 |
| Dec 31, 2023 | 960.00 |
| Dec 31, 2023 | 960.00 |